InKine Visicol

Sodium phosphate tablets for cleansing of the bowel as a preparation for colonoscopy approved by FDA Sept. 21. InKine filed NDA 21-097 on Nov. 23 under the name Diacol. The name was changed to Visicol after FDA determined Diacol was too similar to Watson's calcium channel blocker Dilacor